Cerebellar Ataxia as a Common Clinical Presentation Associated with DNMT1 p.Y511H and a Review of the Literature.

Cerebellar ataxia DNA (cytosine-5)-methyltransferase 1 Deafness Genotype–phenotype correlation Peripheral neuropathy

Journal

Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 24 07 2020
accepted: 23 12 2020
pubmed: 13 1 2021
medline: 18 1 2022
entrez: 12 1 2021
Statut: ppublish

Résumé

The phenotypes of patients with disease-associated variants in DNMT1 have been classified into two syndromes: hereditary sensory and autonomic neuropathy type 1E (HSAN1E, MIM614116, https://www.omim.org/ ) and autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN, MIM604121). The amino acid codon 511 is a hotspot, and p.Y511C is the most frequently observed disease-associated variant among those in HSAN1E patients, whereas there have been only a few reports on patients with p.Y511H. In this study, we report on the cases of a kindred carrying the DNMT1 variant NM_001130823.2:c.1531 T > C (p.Y511H) presenting with the ADCA-DN phenotype. The review of the literature further revealed that later ages at onset and the presence of cerebellar ataxia are the main characteristics of patients carrying the DNMT1 p.Y511H as compared with those carrying DNMT1 p.Y511C. Although HSAN1E and ADCA-DN are proposed to be called DNMT1-complex disorders owing to their overlapping symptoms, this finding suggests a distinct genotype-phenotype correlation regarding the DNMT1 p.Y511H and p.Y511C variants.

Identifiants

pubmed: 33433851
doi: 10.1007/s12031-020-01784-5
pii: 10.1007/s12031-020-01784-5
doi:

Substances chimiques

DNA (Cytosine-5-)-Methyltransferase 1 EC 2.1.1.37
DNMT1 protein, human EC 2.1.1.37

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1796-1801

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Références

Baets J, Duan X, Wu Y, Smith G, Seeley WW, Mademan I et al (2015) Defects of mutant DNMT1 are linked to a spectrum of neurological disorders. Brain 138(4):845–861
doi: 10.1093/brain/awv010
Billiard M (2007) Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition.  Sleep Med Rev 11(5):377–388
Hojo K, Imamura T, Takanashi M, Ishii K, Sasaki M, Imura S et al (1999) Hereditary sensory neuropathy with deafness and dementia: a clinical and neuroimaging study. Eur J Neurol 6(3):357–361
doi: 10.1046/j.1468-1331.1999.630357.x
Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S et al (2011) Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 43(6):595–600
doi: 10.1038/ng.830
Klein CJ, Bird T, Ertekin-Taner N, Lincoln S, Hjorth R, Wu Y et al (2013) DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss. Neurology 80(9):824–828
doi: 10.1212/WNL.0b013e318284076d
Melberg A, Hetta J, Dahl N, Nennesmo I, Bengtsson M, Wibom R et al (1995) Autosomal dominant cerebellar ataxia deafness and narcolepsy. J Neurol Sci 134(1–2):119–129
doi: 10.1016/0022-510X(95)00228-0
Moghadam KK, Pizza F, La Morgia C, Franceschini C, Tonon C, Lodi R et al (2014) Narcolepsy is a common phenotype in HSAN IE and ADCA-DN. Brain 137(6):1643–1655
doi: 10.1093/brain/awu069
Watanabe M, Matsumoto Y, Okamoto K, Okuda B, Mizuta I, Mizuno T (2017) A case of hereditary sensory and autonomic neuropathy type 1E with frontal lobe dysfunction as an initial symptom. Rinsho Shinkeigaku 57(12):753–758
doi: 10.5692/clinicalneurol.cn-001043
Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G et al (2012) Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 21(10):2205–2210
doi: 10.1093/hmg/dds035
Wright A, Dyck PJ (1995) Hereditary sensory neuropathy with sensorineural deafness and early-onset dementia. Neurology 45(3):560–562
doi: 10.1212/WNL.45.3.560

Auteurs

Junko Kanda Kikuchi (JK)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Yu Nagashima (Y)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Tatsuo Mano (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Hiroyuki Ishiura (H)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan. ishiura-tky@umin.org.

Toshihiro Hayashi (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Jun Shimizu (J)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Takashi Matsukawa (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Yaeko Ichikawa (Y)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Yuji Takahashi (Y)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Takashi Kanbayashi (T)

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Japan.

Junichi Kira (J)

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Jun Goto (J)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

Shoji Tsuji (S)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.
International University of Health and Welfare, Chiba, 286-8686, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH